Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
2023-04-21 06:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. An emphasis on quality...
2023-04-12 23:59:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2023-04-12 10:00:00 ET Summary Inflation and (expected) actions by the Federal Reserve continue to dominate market movements even though the turmoil in the financial sector shortly took center stage. Markets have started the new year with very solid gains following expectations ab...
2023-04-08 02:16:45 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-03-23 11:27:27 ET Bayer ( OTCPK:BAYZF ) and Orion Corp. ( OTCPK:ORINY ) have started a late-stage trial examining Nubeqa (darolutmaide) in hormone-sensitive prostate cancer, in patients with high-risk biochemical recurrence. The indication would be for patients who have n...
2023-03-07 09:15:00 ET Summary Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets have started the new year with very solid gains following expectations about a more dovish Federal Reserve and a solid earnings season. My divi...
Summary Bayer reported great results for fiscal 2022 with sales growing in the double digits, core EPS growing 22% and all three segments contributing to growth. And although Bayer is a little cautious for fiscal 2023 and expecting EBITDA and core EPS to decline, we can be optimistic ab...
The European Commission has granted marketing authorization in the European Union (EU) for Orion's ( OTCPK:ORINY ) darolutamide, an oral androgen receptor inhibitor (ARi), plus androgen deprivation therapy (ADT) in combination with docetaxel, for the treatment of patients with m...
Summary Bayer delivered strong FY 2022 results, beating analyst consensus estimates with regards to both topline and earnings. However, markets punished the stock lower following the earnings release, due to a perceived weak 2023 outlook. But investors should consider that EPS proje...
Bayer AG (BAYZF) Q4 2022 Results Earnings Conference Call February 28, 2023, 08:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - Chairman, Chief Executive Officer and Chief Sustainability Officer Rodrigo Santos - President, Crop ...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...